Provepharm Sas Drug Patent Portfolio
Provepharm Sas owns 1 orange book drug protected by 3 US patents Given below is the list of Provepharm Sas's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10927258 | Process for the preparation of Indigotindisulfonate sodium (indigo carmine) | 23 Dec, 2037 | Active |
| US11499050 | Process for the preparation of indigotindisulfonate sodium (indigo carmine) | 23 Dec, 2037 | Active |
| US11845867 | Process for the preparation of indigotindisulfonate sodium (indigo carmine) | 25 Nov, 2036 | Active |
Latest Legal Activities on Provepharm Sas's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Provepharm Sas.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 20 Dec, 2023 | US11845867 |
|
Recordation of Patent Grant Mailed
Critical
| 19 Dec, 2023 | US11845867 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 19 Dec, 2023 | US11845867 |
| Patent eGrant Notification | 19 Dec, 2023 | US11845867 |
| Recordation of Patent eGrant | 19 Dec, 2023 | US11845867 |
| Mail Patent eGrant Notification | 19 Dec, 2023 | US11845867 |
|
Email Notification
Critical
| 30 Nov, 2023 | US11845867 |
|
Issue Notification Mailed
Critical
| 29 Nov, 2023 | US11845867 |
| Dispatch to FDC | 07 Nov, 2023 | US11845867 |
|
Application Is Considered Ready for Issue
Critical
| 07 Nov, 2023 | US11845867 |
|
Issue Fee Payment Received
Critical
| 03 Nov, 2023 | US11845867 |
|
Issue Fee Payment Verified
Critical
| 03 Nov, 2023 | US11845867 |
| Workflow - Drawings Finished | 31 Aug, 2023 | US11845867 |
| Mail PUB other miscellaneous communication to applicant | 22 Aug, 2023 | US11845867 |
|
Email Notification
Critical
| 22 Aug, 2023 | US11845867 |
Provepharm Sas's Family Patents
Provepharm Sas drugs have patent protection in a total of 3 countries. It has a significant patent presence in the US with 57.1% of its patents being US patents. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
Provepharm Sas Drug List
Given below is the complete list of Provepharm Sas's drugs and the patents protecting them.
1. Bludigo
Bludigo is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10927258 | Process for the preparation of Indigotindisulfonate sodium (indigo carmine) |
23 Dec, 2037
(13 years from now)
| Active |
| US11499050 | Process for the preparation of indigotindisulfonate sodium (indigo carmine) |
23 Dec, 2037
(13 years from now)
| Active |
| US11845867 | Process for the preparation of indigotindisulfonate sodium (indigo carmine) |
25 Nov, 2036
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Bludigo's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List